[Bevacizumab goes anterior: antiangiogenic therapy at cornea and conjunctiva].
Cursiefen
C
C
Universitätsaugenklinik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen. ccursiefen@yahoo.com
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000188:drug therapy*; D016510:Corneal Neovascularization / Q000188:drug therapy*; D006801:Humans
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab